Abstract:Purpose: The enhanced relative biological effectiveness (RBE) at the end of the proton range might increase the risk of radiation-induced toxicities. This is of special concern for intracranial treatments where several critical organs at risk (OARs) surround the tumor. In the light of this, a retrospective analysis of dose-averaged linear energy transfer (LETd ) and RBE-weighted dose (DRBE ) distributions was conducted for three clinical cases with suspected treatment-related toxicities following intracranial proton therapy. Alternative treatment strategies aiming to reduce toxicity risks are also presented. Methods: The clinical single-field optimized (SFO) plans were recalculated for 81 error scenarios with a Monte Carlo dose engine. The fractionation DRBE was 1.8 Gy (RBE) in 28 or 30 fractions assuming a constant RBE of 1.1. Two LETd - and α/β-dependent variable RBE models were used for evaluation, including a sensitivity analysis of the α/β parameter. Resulting distributions of DRBE and LETd were analyzed together with normal tissue complication probabilities (NTCPs). Subsequently, four multi-field optimized (MFO) plans, with an additional beam and/or objectives penalizing protons stopping in OARs, were created to investigate the potential reduction of LETd , DRBE , and NTCP. Results: The two variable RBE models agreed well and predicted average RBE values around 1.3 in the toxicity volumes, resulting in an increased near-maximum DRBE of 7-11 Gy (RBE) compared to RBE = 1.1 in the nominal scenario. The corresponding NTCP estimates increased from 0.8%, 0.0%, and 3.7% (RBE = 1.1) to 15.5%, 1.8%, and 45.7% (Wedenberg RBE model) for the three patients, respectively. The MFO plans generally allowed for LETd , DRBE , and NTCP reductions in OARs, without compromising the target dose. Compared to the clinical SFO plans, the maximum reduction in the near-maximum LETd was 56%, 63%, and 72% in the OAR exhibiting the toxicity for the three patients, respectively. Conclusions: Although a direct causality between RBE and toxicity cannot be established here, high LETd and DRBE correlated spatially with the observed toxicities, whereas setup and range uncertainties had a minor impact. Individual factors, which might affect the patient-specific radiosensitivity, were however not included in these calculations. The MFO plans using both an additional beam and proton track-end objectives allowed the largest reductions in LETd , DRBE , and NTCP, and might be future tools for similar cases.

Investigating the potential contribution of inter-track interactions within ultra-high dose-rate proton therapy

A method to implement inter-track interactions in Monte Carlo simulations with TOPAS-nBio and their influence on simulated radical yields following water radiolysis

Voxel-wise dose rate calculation in clinical pencil beam scanning proton therapy

Exploring the Advantages of Intensity-Modulated Proton Therapy: Experimental Validation of Biological Effects Using Two Different Beam Intensity-Modulation Patterns

Charged Particle Radiobiology Beamline Using Tandem Accelerator-Based MeV Protons and Carbon Ions: a Pilot Study on the Track-End Radiation Quality, Variable Biological Effectiveness and Bayesian Beam Dosimetry

Evaluation and Mitigation of the Interplay Effects of Intensity Modulated Proton Therapy for Lung Cancer in a Clinical Setting.

On the interplay effects with proton scanning beams in stage III lung cancer.

The significance of dose heterogeneity on the anti-tumor response of minibeam radiation therapy

Biophysical characterization of collimated and uncollimated fields in pencil beam scanning proton therapy

Sharp dose profiles for high precision proton therapy using focused proton beams

Renormalization of radiobiological response functions by energy loss fluctuations and complexities in chromosome aberration induction: deactivation theory for proton therapy from cells to tumor control

High LET-Like Radiation Tracks at the Distal Side of Accelerated Proton Bragg Peak

Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors

Enabling Clinical Use of Linear Energy Transfer in Proton Therapy for Head and Neck Cancer -- A Review of Implications for Treatment Planning and Adverse Events Study

Normal Tissue Response of Combined Temporal and Spatial Fractionation in Proton Minibeam Radiation Therapy

Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams

The effect of non-ionizing excitations on the diffusion of ion species and inter-track correlations in FLASH ultra-high dose rate radiotherapy

Investigation of hydrogen peroxide yields and oxygen consumption in high dose rate irradiation: a TOPAS-nBio Monte Carlo study

Dose-rate effects and tumor control probability in 177 Lu-based targeted radionuclide therapy: a theoretical analysis

Processing of prompt gamma-ray timing data for proton range measurements at a clinical beam delivery

Cellular Response to Proton Irradiation: A Simulation Study with TOPAS-nBio